Age, years, median | 66 (44–87) |
Gender: m/f, n | 119/41 |
Weightloss >5%/3 month, n (%) | 38 (24) |
Karnofsky Index, n (%) | |
60 | 10 (6) |
70 | 72/45) |
80–100 | 78 (49) |
Histology/cytology, n (%) | |
Squamous cell carcinoma | 104 (63) |
Adenocarcinoma | 43 (26) |
NSC-n. o. s | 17 (11) |
AJCC-stage, n (%) | |
I | 38 (24) |
II | 6 (4) |
III A | 69 (43) |
III B | 47(29) |
Affiliation according PT-Ø, n (%) | |
Group 1 (< 2.5 cm) | 27 (17) |
Group 2 (2.5–4.5 cm) | 94 (57) |
Group 3 (4.5–6.0 cm) | 30 (18) |
Group 4 (> 6.0 cm) | 13 (8) |
Gross tumor volume (ccm, median/mean, range) | |
Group 1 | 17/33 (2–167) |
Group 2 | 50/68 (9–492) |
Group 3 | 92/108 (50–205) |
Group 4 | 163/238 (105–572) |
Tumor localisation, n (%) | |
Central | 44 (27) |
Peripheral | 120 (73) |